# EDGAR Filing Document

**Accession Number:** 0001036262
**File Stem:** 0000891839-26-000114
**Filing Date:** 2026-4
**Character Count:** 7726
**Document Hash:** 759f88c035dc090f2f15efef928b9583
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000891839-26-000114.hdr.sgml**: 20260402

**ACCESSION NUMBER**: 0000891839-26-000114

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20260331

**FILED AS OF DATE**: 20260402

**DATE AS OF CHANGE**: 20260402

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Grant Richard N. Jr.
- **CENTRAL INDEX KEY:** 0001821315

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-36117
- **FILM NUMBER:** 26834851

**MAIL ADDRESS:**
- **STREET 1:** C/O INTEST CORP
- **STREET 2:** 804 EAST GATE DR, SUITE 200
- **CITY:** MT. LAUREL
- **STATE:** NJ
- **ZIP:** 08054
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** INTEST CORP
- **CENTRAL INDEX KEY:** 0001036262
- **STANDARD INDUSTRIAL CLASSIFICATION:** INSTRUMENTS FOR MEAS & TESTING OF ELECTRICITY & ELEC SIGNALS [3825]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 222370659
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 804 EAST GATE DR., SUITE 200
- **CITY:** MT. LAUREL
- **STATE:** NJ
- **ZIP:** 08054
- **BUSINESS PHONE:** 856-505-8800

**MAIL ADDRESS:**
- **STREET 1:** 804 EAST GATE DR., SUITE 200
- **CITY:** MT. LAUREL
- **STATE:** NJ
- **ZIP:** 08054

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[x] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Grant Richard N. Jr.<br><sub>(Last) (First) (Middle)</sub><br>C/O INTEST CORP<br>804 EAST GATE DR, SUITE 200<br><sub>(Street)</sub><br>MT. LAUREL, NJ 08054<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2026-03-31 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[X] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_President & CEO_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>INTEST CORP [ INTT ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Stock | 2026-03-31 |  | D |  | 2465<sup>(1)</sup> | D | $0 | 210265 | D |  |
| Common Stock | 2026-03-31 |  | D |  | 8826<sup>(2)</sup> | D | $0 | 201439 | D |  |
| Common Stock | 2026-03-31 |  | D |  | 17652<sup>(3)</sup> | D | $0 | 183787 | D |  |
| Common Stock | 2026-03-31 |  | D |  | 19380<sup>(4)</sup> | D | $0 | 164407 | D |  |
| Common Stock | 2026-03-31 |  | D |  | 25840<sup>(5)</sup> | D | $0 | 138567 | D |  |
| Common Stock | 2026-03-31 |  | D |  | 13822<sup>(6)</sup> | D | $0 | 124745 | D |  |
| Common Stock | 2026-03-31 |  | D |  | 13822<sup>(7)</sup> | D | $0 | 110923 | D |  |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Employee Stock Option (right to buy) | $7.74 |  |  |  |  |  |  | <sup>(8)</sup> | 2035-03-16 | Common Stock | 581 |  | 581 | D |  |
| Employee Stock Option (right to buy) | $7.74 |  |  |  |  |  |  | <sup>(8)</sup> | 2035-03-16 | Common Stock | 10846 |  | 10846 | D |  |
| Employee Stock Option (right to buy) | $11.33 |  |  |  |  |  |  | <sup>(8)</sup> | 2034-03-05 | Common Stock | 15268 |  | 15268 | D |  |
| Employee Stock Option (right to buy) | $16.06 |  |  |  |  |  |  | <sup>(8)</sup> | 2033-03-07 | Common Stock | 12741 |  | 12741 | D |  |
| Employee Stock Option (right to buy) | $9.76 |  |  |  |  |  |  | <sup>(8)</sup> | 2032-03-08 | Common Stock | 25692 |  | 25692 | D |  |
| Employee Stock Option (right to buy) | $10.62 |  |  |  |  |  |  | <sup>(8)</sup> | 2031-03-09 | Common Stock | 112000 |  | 112000 | D |  |

---

### Footnotes:

(1) Unvested shares forfeited related to Mr. Grant's March 8, 2023 time-vesting restricted stock award.

(2) Unvested shares forfeited related to Mr. Grant's March 6, 2024 time-vesting restricted stock award.

(3) Unvested shares forfeited related to Mr. Grant's March 6, 2024 performance-vesting restricted stock award.

(4) Unvested shares forfeited related to Mr. Grant's March 17, 2025 time-vesting restricted stock award.

(5) Unvested shares forfeited related to Mr. Grant's March 17, 2025 performance-vesting restricted stock award.

(6) Unvested shares forfeited related to Mr. Grant's March 16, 2026 time-vesting restricted stock award.

(7) Unvested shares forfeited related to Mr. Grant's March 16, 2026 performance-vesting restricted stock award.

(8) This option is fully exercisable as of the date of this report.

**Signature:** /s/ Richard N. Grant, Jr.  
**Date:** 2026-04-02

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**